Nucleic Acid Testing Market: Size, Growth, Regional Analysis, And Market Analysis

Nucleic acid testing:

Nucleic acid testing (NAT) is a molecular method for detecting viruses, bacteria, and pathogenic nucleic acids in a patient's blood, tissue, or urine. It is used for forensic purposes and to diagnose infections transferred through blood transfusions, hereditary disorders, and cancer. It entails nucleic acid extraction, target N.A. amplification, and target amplicon N.A. detection, as well as sample pooling.

Kits and consumables for polymerase chain reaction (PCR), strand displacement amplification (SDA), ligase chain reaction (LCR), transcription-mediated amplification (TMA), and N.A. sequence-based amplification (NASBA) techniques are included in the testing. NAT is also used to diagnose diseases that have no visible symptoms and to correct incorrect reaction interpretations.

Market Growth:

The global Nucleic Acid Testing Market was valued at USD 2,585.05 million in 2020 and is predicted to grow at a CAGR of 10.11 per cent from 2020 to 2026, to reach USD 4,607.45 million 2026.

The increased occurrence of infectious diseases such as cancer and genetic disorders and the rising need for technological developments in testing methods are driving the global market for nucleic acid testing. Nucleic acid testing aid in diagnosing the condition while also providing an extra layer of blood screening. The nucleic acid testing market is appealing since it can assist shorten the infectious period due to its advantage of early detection and capacity to deliver reliable analysis.

The worldwide nucleic acid testing market is divided into nucleic acid test kits and consumables based on product type. Polymerase chain reaction (PCR), Ligase chain reaction (LCR), Transcription-mediated amplification (TMA), Whole Genome Sequencing, and other types of nucleic acid test kits are available.

Regional Analysis:

Compared to marketplaces in other regions, North America dominates the global nucleic acid amplification testing market in terms of revenue contribution. This is due to the region's presence of potential market participants as well as well-developed healthcare infrastructure.

The market for nucleic acid amplification testing in Europe is the second-largest revenue contributor, followed by markets in the Asia Pacific, Latin America, and the Middle East and Africa. Over the next ten years, the Asia Pacific market is expected to grow at a higher rate in terms of revenue than the rest of the world.

Key Players:

Abbott Laboratories, Beckman Coulter, Inc., Becton, Dickinson and Company, BioMérieux SA, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., Grifols, S.A., Illumina, Inc., Novartis Ag, Qiagen N.V., Quest Diagnostics Incorporated, Siemens Ag, and Tecan Group Ltd. are the major key players of nucleic acid testing market.


Comments

Popular posts from this blog

Significance of EHealth Software And Services

The OKR Software Market Is Estimated To Increase At A CAGR Of 12.60 Percent During The Forecast Period

Broadcast Switchers Market Report | the Demand for the Market Will Drastically Increase in the Future